What is Adenocard (adenosine) used for?
Adenocard is the brand name for adenosine, an injectable medication used to help diagnose and treat certain heart rhythm problems (supraventricular tachycardias), particularly when a rapid rhythm is thought to be driven through the atrioventricular (AV) node.
How does Adenocard work?
Adenosine temporarily slows conduction through the AV node. That brief slowing can interrupt some types of re-entrant supraventricular tachycardia, and it can also help clinicians identify whether a fast rhythm is dependent on AV nodal conduction.
What conditions is Adenocard associated with in clinical use?
Adenosine injection is commonly used in emergency or acute settings for:
- Terminating AV node–dependent supraventricular tachycardias (e.g., certain re-entrant tachycardias)
- Helping distinguish among types of narrow-complex tachycardias based on how the rhythm responds to AV nodal blockade
What side effects or risks are patients commonly concerned about?
Because adenosine acts quickly and affects heart conduction, patients and clinicians watch for short-term effects such as:
- Flushing, chest discomfort, or shortness of breath sensations
- Transient changes in heart rhythm as the drug slows AV conduction
In practice, clinicians also screen for situations where rapid AV nodal effects could be risky.
Is there a patent or generic version of Adenocard?
To check patent status, exclusivity, and whether generics or authorized alternatives exist, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/ (search for “Adenocard” or “adenosine injection”).
Which competitors are typically considered?
Adenosine injection competes with other approaches to rapid supraventricular tachycardia, including other antiarrhythmic drugs and non-drug treatments depending on the rhythm diagnosis and patient stability.
What to look for on the label (dose form matters)
If you are searching for Adenocard specifically, make sure you match the exact product (adenosine injection) and concentration, since availability and labeling can differ by market.
Sources
- https://www.drugpatentwatch.com/